# FortePhest

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fortephest

- Industry: Chemicals
- Headquarters: Israel
- Website: www.fortephest.com
- Total disclosed funding: $0.6M
- Latest round: Series B (Feb 10, 2022)
- Investors on record: 4

## About

Based in Israel, and founded in 2017 by CEO States Alex Kozak, Mark Safro, and Israel Shapiro, FortePhest is a biotechnology company focused on crop protection that develops innovative products to control weeds that are resistant to herbicides. In February 2022, FortePhest raised Series B financing co-led by BASF Venture Capital and Orbia Ventures, with participation from South Israel Bridging Fund. Returning investor Sherpa Innoventures also participated in the round.

The company operates as a developer of products to control both regular weeds and weeds which are resistant to herbicides. This is done by exploring novel Mechanisms of Action (MOA) discovered in plants, that can control resistant weeds by disrupting the 3D structure of their proteins, enabling users to control both sensitive weeds and weeds which are resistant to currently available herbicides. The products in the company's pipeline include H-Forte™ and H-Forte™ for Glyphosate (Roundup).

FortePhest plans to use the Series B funding to accelerate its development programs and work with potential global strategic partners to commercialize novel crop protection products that meet future regulatory requirements.

## Funding rounds

- Series B, Feb 10, 2022 — BASF, Sherpa Innoventures, Orbia Ventures, South Israel Bridging Fund
- Seed, Jan 1, 2018, $0.6M — Sherpa Innoventures

## Investors

- Sherpa Innoventures (https://capitalatlas.ai/funds/sherpa-innoventures) — Seed, Series B
- BASF (https://capitalatlas.ai/funds/basf) — Series B
- Orbia Ventures (https://capitalatlas.ai/funds/orbia-ventures) — Series B
- South Israel Bridging Fund — Series B